268 related articles for article (PubMed ID: 29051083)
1. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA
Szepanowski F; Szepanowski LP; Mausberg AK; Kleinschnitz C; Kieseier BC; Stettner M
Neurosci Lett; 2018 Jan; 662():136-141. PubMed ID: 29051083
[TBL] [Abstract][Full Text] [Related]
2. LPA
Szepanowski F; Winkelhausen M; Steubing RD; Mausberg AK; Kleinschnitz C; Stettner M
J Neuroinflammation; 2021 Dec; 18(1):293. PubMed ID: 34920725
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.
Anliker B; Choi JW; Lin ME; Gardell SE; Rivera RR; Kennedy G; Chun J
Glia; 2013 Dec; 61(12):2009-22. PubMed ID: 24115248
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.
Nagai J; Uchida H; Matsushita Y; Yano R; Ueda M; Niwa M; Aoki J; Chun J; Ueda H
Mol Pain; 2010 Nov; 6():78. PubMed ID: 21062487
[TBL] [Abstract][Full Text] [Related]
5. Myelin-related gene silencing mediated by LPA
Tsukahara R; Ueda H
J Pharmacol Sci; 2016 Oct; 132(2):162-165. PubMed ID: 27681370
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling.
Weiner JA; Fukushima N; Contos JJ; Scherer SS; Chun J
J Neurosci; 2001 Sep; 21(18):7069-78. PubMed ID: 11549717
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid and its receptor LPA
Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
[TBL] [Abstract][Full Text] [Related]
9. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor
Hoshino Y; Okuno T; Saigusa D; Kano K; Yamamoto S; Shindou H; Aoki J; Uchida K; Yokomizo T; Ito N
FASEB J; 2022 Apr; 36(4):e22236. PubMed ID: 35218596
[TBL] [Abstract][Full Text] [Related]
11. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
13. Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve.
Balakrishnan A; Stykel MG; Touahri Y; Stratton JA; Biernaskie J; Schuurmans C
PLoS One; 2016; 11(4):e0153256. PubMed ID: 27058953
[TBL] [Abstract][Full Text] [Related]
14. LPA-mediated demyelination in ex vivo culture of dorsal root.
Fujita R; Kiguchi N; Ueda H
Neurochem Int; 2007 Jan; 50(2):351-5. PubMed ID: 17056157
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid activates satellite glia cells and Schwann cells.
Robering JW; Gebhardt L; Wolf K; Kühn H; Kremer AE; Fischer MJM
Glia; 2019 May; 67(5):999-1012. PubMed ID: 30637823
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination.
Yang DP; Kim J; Syed N; Tung YJ; Bhaskaran A; Mindos T; Mirsky R; Jessen KR; Maurel P; Parkinson DB; Kim HA
J Neurosci; 2012 May; 32(21):7158-68. PubMed ID: 22623660
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells.
Li Y; Gonzalez MI; Meinkoth JL; Field J; Kazanietz MG; Tennekoon GI
J Biol Chem; 2003 Mar; 278(11):9585-91. PubMed ID: 12524451
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
Inoue M; Ma L; Aoki J; Chun J; Ueda H
Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210
[TBL] [Abstract][Full Text] [Related]
19. Schwann cell dedifferentiation-associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination.
Jang SY; Yoon BA; Shin YK; Yun SH; Jo YR; Choi YY; Ahn M; Shin T; Park JI; Kim JK; Park HT
Glia; 2017 Nov; 65(11):1848-1862. PubMed ID: 28795433
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
